European Pharmaceutical Review

JULY 5, 2024

Following the Labour Party’s win yesterday in the UK 2024 General Election, industry representatives have voiced their opinions on what this could mean for the future of the pharmaceutical industry under the new government. Association of the British Pharmaceutical Industry (ABPI) The new government now needs to hit the ground running and rapidly set out a clear, detailed plan” “During its campaign, Labour was right to single out the UK’s life sciences sector as a critical partner fo

Pharma 98

Pharma Government Safety Medicine 98

MedCity News

JULY 5, 2024

In our eagerness for innovation, there’s a risk that we ignore existing effective, readily-available treatments. The post Why Wait? The Urgency of Accessible PTSD Treatments Now appeared first on MedCity News.

103

103

Pharmaceutical Technology

JULY 5, 2024

Fucaso, a BCMA CAR T-cell therapy, is co-developed by Innovent and IASO Bio and was approved to treat multiple myeloma in China last month.

97

97

MedCity News

JULY 5, 2024

When someone is sick or worried about an ailing loved one, they are already under stress. A good digital wayfinding experience can reduce that strain. The post True Blue-Dot Navigation in Healthcare is Both Harder and More Important Than You Think appeared first on MedCity News.

Healthcare 89

Healthcare Healthcare 89

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Pharmaceutical Technology

JULY 5, 2024

Approval is based on positive data from the Phase III FLAURA2 trial where Tagrisso plus chemotherapy showed PFS of 24.4 months.

98

98

PharmaTimes

JULY 5, 2024

The neurodegenerative disease currently affects more than 200,000 people worldwide

Leads 120

Leads 120

PharmaTimes

JULY 5, 2024

Pneumococcus is the leading cause of pneumonia, meningitis and sepsis worldwide

Leads 110

Leads 110

pharmaphorum

JULY 5, 2024

After Labour landslide in UK general election, former shadow health secretary West Streeting sets out his objectives for the NHS.

105

105

PharmaTech

JULY 5, 2024

Shawn Davis, CEO of Liberate Bio, shares some insights into the world of drug discovery, development, and delivery, as well as process optimization

Medicine 69

Medicine 69

MedTechVets

JULY 5, 2024

JUL 6TH – We were proud to interview MedTechVet Traing Program Mentor, Scott Nelson. Scott is currently the Marketing Strategist for Wound Management and Surgical Reconstruction at LifeNet Health. Veterans have so much to offer but often limit their self-promotion which makes entering an entirely new industry very difficult. Our med tech space would benefit so much from these transitioning members that have incredible skills and experience.

Networking 59

Networking Medical Recruitment Specialization 59

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

PharmExec

JULY 5, 2024

In an interview with Pharm Exec Associate Editor Don Tracy, Kathy Lee-Sepsick, Founder, CEO, Femasys, offers a description of how Femaseed works to support women who struggle with infertility.

52

52

Pharmaceutical Technology

JULY 5, 2024

BioSenic and Medsenic filed patent application with the USPTO to extend the protection for the use of arsenic trioxide (ATO) for sepsis.

59

59

PharmaTech

JULY 5, 2024

Although advancements in analytical drug substance testing are being made, the increasing diversity of the therapeutic landscape is necessitating further innovation.

53

53

Pharmaceutical Technology

JULY 5, 2024

The UK life science industry is crossing its fingers as a Labour government takes the reigns following 14 years of Conservative rule.

Government 59

Government 59

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

PharmExec

JULY 5, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52

Pharma FDA 52

Pharmaceutical Technology

JULY 5, 2024

Whilst Regeneron and Sanofi secured approval in Europe for COPD, the FDA has delayed Dupixent’s application review for the disease in the US.

FDA 52

FDA 52

Pharmaceutical Commerce

JULY 5, 2024

An observational, retrospective cohort study undergoes this investigation in individuals 24 years of age or older.

Patients 52

Patients 52

Pharmaceutical Technology

JULY 5, 2024

The EMA has validated Philogen and Sun Pharmaceutical’s marketing authorisation application (MAA) for Nidlegy, a treatment for melanoma.

Marketing 52

Marketing 52

Advertisement

Pharmaceutical Commerce

JULY 5, 2024

The latest news for pharma industry insiders.

Pharma 52

Pharma Manufacturing Marketing FDA 52

Pharmaceutical Technology

JULY 5, 2024

The UK took to the polls on 4 July 2024 and voted in a new government. How will a Labour government look for the clinical trial sector?

Government 52

Government 52

Pharmacy Times

JULY 5, 2024

Pharmacists can play a crucial role in diabetes management by implementing standing order protocols for medication titration and serving as a bridge between patients and other health care providers.

Medical 37

Medical Patients Management 37

Pharmaceutical Technology

JULY 5, 2024

As the UK transitions into a Labour party government, the pharma industry urges for boosted investment and talent attraction.

Government 52

Government Pharma 52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmacy Times

JULY 5, 2024

Vitamin D could mitigate negative impacts on neurobehavior and weight gain caused by consumption of monosodium glutamate (MSG).

55

55

Pharmaceutical Technology

JULY 5, 2024

SL-APO is marketed by Bial in France, Germany, Spain and the UK for the on-demand treatment of leveodopa wear-off.

Marketing 52

Marketing 52

Pharmacy Times

JULY 5, 2024

Alan Chin, PharmD, BCOP, presents an overview of the most prevalent and common adverse reactions associated with EGFR-targeted therapies in metastatic NSCLC and shares strategies to mitigate toxicities, with a focus on managing dermatologic events such as rash and itching.

Management 26

Management 26

Pharmaceutical Technology

JULY 5, 2024

HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer).

40

40

Advertisement

Distribution

Pharmacy Times

JULY 5, 2024

A pharmacy expert explores infusion-related reactions associated with amivantamab, providing guidance on managing and preventing these reactions, while also addressing the role of split-dosing, premedications, and steroids in the treatment paradigm.

Management 26

Management Medical 26

Pharmaceutical Technology

JULY 5, 2024

CTX-310 is under clinical development by CRISPR Therapeutics and currently in Phase II for Heterozygous familial hypercholesterolemia (heFH).

40

40

Pharmacy Times

JULY 5, 2024

In 2 different dose groups, the majority of patients with eosinophilic esophagitis aged 1 to 11 achieved histologic remission at week 16 compared with patients treated with placebo.

Patients 20

Patients 20

Pharmaceutical Technology

JULY 5, 2024

CTX-310 is under clinical development by CRISPR Therapeutics and currently in Phase II for Homozygous Familial Hypercholesterolemia (HoFH).

40

40

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales